A detailed history of Hsbc Holdings PLC transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 44,728 shares of VOR stock, worth $38,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,728
Previous 49,038 8.79%
Holding current value
$38,466
Previous $49,000 36.73%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.1 $3,017 - $4,741
-4,310 Reduced 8.79%
44,728 $31,000
Q2 2024

Aug 12, 2024

BUY
$1.0 - $2.2 $31,333 - $68,932
31,333 Added 176.97%
49,038 $49,000
Q1 2024

May 15, 2024

BUY
$1.8 - $2.85 $31,869 - $50,459
17,705 New
17,705 $41,000

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $32.7M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.